Table 3.
Level of Mucin 5B in serum and stimulated and unstimulated saliva of OLP patients and controls.
| Control | Case | P-value | |
|---|---|---|---|
| Mucin 5B in serum (ng/ml) | 417.1 ± 49.2 | 614.8 ± 63.0 | 0.016* |
| Mucin 5B in stimulated saliva (ng/ml) | 203.1 ± 37.3 | 200.4 ± 11.5 | 0.944 |
| Mucin 5B in unstimulated saliva (ng/ml) | 466.1 ± 28.1 | 190.8 ± 26.0 | 0.0001* |
| Released Mucin 5B in unstimulated saliva (ng/min) | 334.7 ± 42.6 | 79.6 ± 10.6 | 0.0001* |
| Released Mucin 5B in stimulated saliva (ng/min) | 274.2 ± 72.5 | 122.1 ± 14.3 | 0.044* |
| Unstimulated saliva flow (ml/min) | 0.72 ± 0.08 | 0.45 ± 0.06 | 0.008* |
| Stimulated saliva flow (ml/min) | 1.27 ± 0.26 | 0.68 ± 0.07 | 0.035* |
Data were reported as mean ± standard deviation.
*Indicates significant differences. P < 0.05 was considered statistically significant.